Protective Effect of Recombinant Human Leukemia Inhibitory Factor against Thrombocytopenia in Carboplatin‐treated Mice

The protective effect of recombinant human leukemia inhibitory factor (rhLIF) against development of throrabocytopenia in carboplatin (CBDCA; cis‐diammine‐l, l‐cyclobutane dicarboxylate platinum II)‐treated mice was examined. The optimal dose of rhLIF was determined by administering doses of rhLIF r...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Yasuto, Kikuchi, Yasufumi, Matsuzaki, Junichi, Kajimura, Naoko, Ohue, Chiharu, Yamaguchi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1997
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921474/
https://www.ncbi.nlm.nih.gov/pubmed/9263536
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00422.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921474/
https://www.ncbi.nlm.nih.gov/pubmed/9263536
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00422.x

Ejemplares similares